What’s the Best Treatment for Obstructive Sleep Apnea (OSA)?

CPAP vs. Medication: Which Obstructive Sleep Apnea (OSA) Treatment Is More Effective?

CPAP vs. Medication: Which Obstructive Sleep Apnea (OSA) Treatment Is More Effective?
Everyday Health

If you have obstructive sleep apnea (OSA), you might be offered a choice between instant breathing support and a long-term approach to target the condition’s root causes.

Continuous positive airway pressure (CPAP) therapy is the gold standard treatment for OSA; this breathing device can correct the condition literally overnight. The newest treatment for OSA, on the other hand, the medication tirzepatide (Zepbound), does not offer immediate relief, but it helps drive weight loss and better metabolic health, tackling one of OSA’s major root causes.

Graphic titled Obstructive Sleep Apnea (OSA) Treatments: CPAP vs. Tirzepatide. Speed – CPAP: Instant sleep quality improvement, Tirzepatide: Gradual sleep quality improvement. How it works – CPAP: Air pressure forces the airway open during sleep
Everyday Health

CPAP: The Benefits

“CPAP is still considered the first-line treatment for obstructive sleep apnea,” says Atul Malhotra, MD, a sleep apnea researcher, pulmonologist, sleep medicine specialist, and research chief of pulmonary, critical care, and sleep medicine at UC San Diego Health in California. CPAP devices deliver pressurized air through a mask worn over your nose or your nose and mouth, keeping your airways open during sleep.

A research review comparing OSA treatments asserts that CPAP therapy is the most effective option for improving daytime sleepiness and reducing the apnea-hypopnea index (AHI). A measurement of the average number of times you stop breathing during sleep, AHI is the primary metric used to diagnose the severity of sleep apnea. CPAP reduces AHI by nearly 31 breathing disruptions per hour.

Fewer breathing interruptions leads to better sleep quality, helping people with OSA wake up feeling more rested, have less daytime sleepiness, and experience mood improvements.

Though CPAP does not directly treat other aspects of your health, substantially improving your sleep quality can have many downstream benefits. Consistent CPAP use may offer long-term improvements such as:

  • Improved blood pressure
  • Reduced risk of heart disease, heart attack, and stroke
  • Protected cognitive function (including memory and thinking)

CPAP: The Downsides

While effective, CPAP therapy has its drawbacks.

“There is some stigma associated with CPAP machines,” says Dr. Malhotra. “Some people don’t want others to know they’re wearing it to bed at night. It’s not perceived as good for intimacy, and there could be irritation on the nose and face from the mask.”

In addition to sometimes being uncomfortable to wear, CPAP machines can be cumbersome when traveling, both of which make consistent use difficult.

Some users also experience congestion, runny nose, dry mouth, or nosebleeds when using a CPAP machine. These side effects typically occur when the air is cold and dry and can often be resolved by adding a humidifier to your bedroom.

Despite these drawbacks, CPAP therapy is often well tolerated and can have transformative benefits for people with OSA, says Malhotra.

Tirzepatide: The Benefits

Tirzepatide (Zepbound) is a weekly injectable GLP-1/GIP medication approved by the U.S. Food and Drug Administration for treating obesity.

Though not everyone who has obstructive sleep apnea is overweight or has obesity, excess weight is a major risk factor for the condition. “When people gain weight, they can deposit fat around the tongue, upper airway, in the abdomen, and other areas that can contribute to airway collapse,” says Malhotra. Reducing body weight with the help of medications like tirzepatide is one approach to treating OSA: “If the weight comes down, it can help improve sleep apnea.”

An umbrella review of available sleep apnea interventions suggests tirzepatide is the second most effective treatment for reducing AHI, cutting breathing disruptions by nearly 22 events per hour. It can also help improve feelings of daytime sleepiness that often accompany OSA.

And the potential overall health improvements are significant. By directly addressing obesity, a root cause of OSA in many people, tirzepatide provides significant metabolic benefits, including:

  • Weight loss
  • Improved blood sugar control
  • Reductions in total and low-density lipoprotein (LDL, or “bad”) cholesterol and triglycerides

Tirzepatide: The Downsides

Like any medication, tirzepatide carries potential risks and side effects. Some people who take tirzepatide experience gastrointestinal upset, such as nausea, vomiting, diarrhea, or constipation.

It can also take longer to see improvements in OSA once you start taking tirzepatide, compared with CPAP therapy. Research shows that early changes in body weight and OSA severity can occur after one month, with more significant results taking four to five months to appear.

Meanwhile, many people notice improved sleep after one night of CPAP therapy.

“There are also cost considerations, because weight loss medications can be expensive,” says Malhotra.

CPAP vs. Tirzepatide: Who Should Choose Which Treatment?

“If a patient has sleep apnea, they should be considered for CPAP,” says Malhotra. People with obesity should focus on diet and exercise to lower body weight, as well as be considered for tirzepatide use, he says. Some doctors will recommend using both treatments at the same time, to improve sleep quality immediately while also treating OSA’s root causes.

“Some people who use Zepbound for moderate or severe apnea who start with a body mass index over 30 will not need to use CPAP once they’ve decreased their weight,” says Chafen Hart, MD, a sleep medicine specialist at National Jewish Health in Denver.

While CPAP therapy is generally safe and well tolerated, it may not be a good choice for people who:

  • Experience severe nausea and vomiting
  • Find the mask claustrophobic
  • Have conditions like chronic obstructive pulmonary disease
  • Have facial injuries or burns
  • Recently underwent facial, airway, or stomach surgery
Meanwhile, tirzepatide isn’t recommended for people with medullary thyroid cancer, a rare cancer in the thyroid gland, or multiple endocrine neoplasia syndrome type 2, a rare genetic disorder that increases one’s risk of thyroid tumors.

Other Treatments for OSA

CPAP and tirzepatide aren’t the only options available for treating sleep apnea. Alternative treatments that may work for certain people include the following:

  • Dental Devices These are worn in your mouth and pull your jaw or tongue forward to keep your airway open while you sleep.

    “Dental devices can be useful in people with mild apnea who ... [have] a bit of an underbite, a small or narrow palate, or for whom the tongue is the major issue preventing them from breathing at night,” says Dr. Hart.
  • Hypoglossal Nerve Stimulators These are surgically implanted devices that shock the tongue to move it away from your airway during sleep. This is a major surgery, says Hart, and is only used for people with severe sleep apnea who haven’t tolerated other treatments.

  • ENT Surgery There are multiple ear, nose, and throat surgeries that can be used to treat OSA, including tissue removal, jaw repositioning, and the creation of a new airway.

    “ENT surgery is limited to those with a very obvious area for intervention in the upper airway and is often our last recommendation,” says Hart.

Discuss your options with your healthcare provider to find the best treatment or combination of treatments for your situation.

Healthy lifestyle changes, including exercising regularly, prioritizing sleep quality, and eating a balanced diet that limits or excludes alcohol, can supplement traditional OSA treatments. Diet and exercise are especially important if obesity or excess weight is contributing to your OSA, says Malhotra.

Side-sleeping positions may also help keep your airway open, though Malhotra says the benefit is likely marginal.

The Takeaway

  • CPAP therapy is considered the most effective method for immediately reducing breathing disruptions and improving daytime sleepiness in people with OSA, though some users find the machines cumbersome or uncomfortable.
  • The second most effective treatment for reducing breathing disruptions, tirzepatide (Zepbound) treats sleep apnea by promoting weight loss to reduce airway obstruction, although the results take months to appear, as opposed to the overnight relief provided by CPAP therapy.
  • Doctors generally recommend CPAP for most sleep apnea patients, but those with obesity may eventually eliminate the need for a machine if they achieve significant weight loss through medication and lifestyle changes.

Resources We Trust

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. CPAP Machine. Cleveland Clinic. July 11, 2024.
  2. Figard C et al. Effect of Sleep Apnoea Interventions on Multiple Health Outcomes: An Umbrella Review of Meta-Analyses of Randomised Controlled Trials. eClinicalMedicine. November 2025.
  3. CPAP. National Heart, Lung, and Blood Institute. March 24, 2022.
  4. FDA Approves New Medication for Chronic Weight Management. U.S. Food and Drug Administration. November 8, 2023.
  5. Sokary S et al. The Promise of Tirzepatide: A Narrative Review of Metabolic Benefits. Primary Care Diabetes. June 2025.
  6. Farzam K et al. Tirzepatide. StatPearls. February 20, 2024.
  7. Malhotra A et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. The New England Journal of Medicine. June 21, 2024.
  8. Djonlagic I et al. First-Night of CPAP: Impact on Memory Consolidation, Attention and Subjective Experience. Sleep Medicine. February 27, 2015.
  9. Pinto VL et al. Continuous Positive Airway Pressure. StatPearls. July 7, 2025.
  10. Oral Appliances for Sleep Apnea. Cleveland Clinic. April 19, 2024.
  11. Sleep Apnea Implant. Cleveland Clinic. February 18, 2025.
  12. Sleep Apnea. Mayo Clinic. December 9, 2025.
Abhinav Singh

Abhinav Singh, MD

Medical Reviewer

Abhinav Singh, MD, is a board-certified sleep medicine specialist and the medical director of the Indiana Sleep Center. He is also an associate clinical professor at Marian University College of Osteopathic Medicine in Indianapolis, where he developed and teaches a sleep medicine rotation.

Dr. Singh’s research and clinical practice focus on sleep disorders, including excessive daytime sleepiness, narcolepsy, sleep apnea, insomnia, and sleep education.

Singh is a peer reviewer for the Journal of Clinical Sleep Medicine, Sleep Health (from the National Sleep Foundation) and the Journal of Sleep Disorders: Treatment and Care, and is coauthor of the book Sleep to Heal: 7 Simple Steps to Better Sleep. He has received several Top Doctor recognitions and is the sleep specialist for the Indiana Pacers NBA team.

He lives in the Indianapolis area and enjoys music production and racquet sports.

Bedosky-bio

Lauren Bedosky

Author
Lauren Bedosky is an experienced health and fitness writer. She regularly contributes to top websites and publications like Men's Health, Women's Health, MyFitnessPal, SilverSneakers, Runner's World, Experience Life, Prevention, AARP, Blue Cross and Blue Shield, UnitedHealthcare, Livestrong, Fitness, Shape, Family Circle, Healthline, Self, Redbook, and Women's Running.

When she's not writing about health and fitness — her favorite topics being anything related to running and strength training — she's reading up on the latest and greatest news in the field and working on her own health goals.